Skip to content
healthcare.dev

Regadenoson

NDC 43598-616, Regadenoson, injection, from Dr. Reddy's Laboratories Inc..

Product NDC
43598-616
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213210
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-616 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON ANHYDROUS.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
43598-616-11435980616115 mL in 1 CARTON (43598-616-11)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/03ef6420-8190-a404-f7f6-def1864a77de
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=43598-616

Use it

Look up 43598-616 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-616 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-616. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.